Role of Hazelnut Consumption in Improving Micronutrient Status in Older Adults

NCT ID: NCT03485989

Last Updated: 2019-08-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

41 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-06-22

Study Completion Date

2017-12-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

With advancing age, older adults are susceptible to vitamin and mineral deficiencies for a variety of reasons. Nutrient-dense food sources of vitamin E and other key vitamins and minerals, like hazelnuts, may offer a simple means of improving nutritional status of healthy older adults.

This hypothesis is that individuals eating hazelnuts everyday will result in measurable increases in magnesium and vitamin E levels, two under-consumed micronutrients among older adults. Thus, subjects will consume two ounces (56 g) of hazelnuts each day for sixteen weeks. Investigators will measure vitamin E and magnesium levels along with a general assessment of micronutrient status as primary outcomes. Since nuts are nutrient-rich sources of unsaturated fatty acids but low in carbohydrates, changes in fasting glucose, lipid and lipoprotein profiles, and BMI will also be determined (secondary outcomes).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Older adults are at increased risk of various chronic diseases where inadequate levels of vitamins and minerals may play a significant role, including cardiovascular disease, Alzheimer's disease, liver disease, and cancer. Older adults are increasingly more susceptible to vitamin and mineral deficiencies with changes in dietary preferences, changes in socioeconomic status, decreased consumption of a variety of foods, poor absorption in the gut, and an increased demand for many of these micronutrients with advanced age.

Epidemiological studies and recent clinical trials have shown that use of multivitamin/mineral or single nutrient supplements, such as vitamin E, have beneficial effects on disease risk, but many people are hesitant to use dietary supplements due to reports of ineffectiveness or potential negative effects. However, food sources of vitamin E and other key vitamins and minerals continue to show health benefits. As an alternative to mandating consumption of multivitamin and mineral supplements or food fortification, a dietary solution is to increase consumption of nutrient-dense foods, like hazelnuts.

Tree nuts, including hazelnuts, contain a wide variety of vitamins and minerals, and are particularly good source of vitamin E and magnesium, two "shortfall nutrients" that are lacking in the typical American diet. Over 90% of U.S. adults do not meet recommended intake levels of vitamin E, and 60% do not get enough magnesium. Tree nuts are also a good source of protein and fiber and are high in healthful unsaturated fatty acids and phytochemicals such as flavonoids and phytosterols.

Most clinical studies on the benefits of nut consumption have been conducted using almonds and walnuts, with hazelnuts used less frequently. However, the health benefits of consuming hazelnuts have been demonstrated in many clinical trials, including lower blood glucose levels, alterations in blood lipids, and declines in biomarkers of oxidative stress. Although several clinical trials have investigated nutritional impact of hazelnuts in adults, no clinical trials with hazelnuts have focused on examining micronutrient status and potential health benefits only in older (≥55 years) adults.

Determination of body status of many micronutrients can be difficult, especially so the evaluation of vitamin E levels when age is considered as a factor. Although serum α-tocopherol levels are generally higher in adults above the age of 50 compared to younger adults, the increased prevalence of hypercholesterolemia in older adults makes interpretation of circulating α-tocopherol levels difficult. Alternatively, urinary α- and γ-carboxyethyl hydroxychromanol (α- and γ-CEHC) is believed to be a biomarker of α- and γ-tocopherol status that changes with vitamin E intake. In particular, low α-CEHC excretion is considered a reliable marker of poor α-tocopherol status, while an increase in α-CEHC is indicative of adequate α-tocopherol status.

The objective of this study was to determine whether daily hazelnut consumption by healthy older adults for 16 weeks improves biomarkers of micronutrient status, especially vitamin E and magnesium. For a detailed assessment of vitamin E status, plasma α- and γ-tocopherol concentrations were determined together with urinary α- and γ-CEHC levels. In addition, a commercially available lymphocyte proliferation assay was utilized to evaluate the status of several other micronutrients. Since hazelnut consumption is reported to reduce blood lipids and improve glucose homeostasis, these biomarkers were also monitored in our study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nutrition Poor Micronutrient Deficiency Aging

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hazelnuts

Participants given 2 ounces (\~57 grams) of dry roasted hazelnuts to consume each day.

Group Type EXPERIMENTAL

Hazelnuts

Intervention Type OTHER

Dry roasted, individually packaged hazelnuts provided from the Hazelnuts Marketing Board of Oregon

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hazelnuts

Dry roasted, individually packaged hazelnuts provided from the Hazelnuts Marketing Board of Oregon

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Must be generally healthy
* Women must be post-menopausal (12 months period-free) or surgically sterile.
* Must be willing to eat two ounces (56 g) of dry roasted hazelnuts each day during the study
* Must refrain from taking nutritional supplements during the study
* Must follow a diet that excludes all nuts (other than those supplied), seeds, and other vitamin E-rich foods (see Restricted Foods and Supplements document)
* Must be willing to complete food frequency questionnaires
* Must be willing to give blood samples on 3 separate occasions and urine on 2 separate occasions

Exclusion Criteria

* Current or past (two years) use of any tobacco (including e-cigarettes) and marijuana products
* Allergy to any nut including tree nuts and peanuts, or hazelnut pollen
* History of asthma
* Vitamin E supplement use during the last three months or regular use of vitamin E-enriched nutritional drinks (e.g. Ensure)
* Regular nut eaters: individuals that regularly consume \> 3.5 ounces (112 g) of almonds, hazelnuts and/or sunflower seeds per week in any form (e.g. nuts, nut butters, nut oil, etc.), and no more than 10 mg alpha-tocopherol (vitamin E) per day from their diet.
* Bariatric surgery (e.g. gastric bypass, gastric banding, sleeve gastrectomy, etc.), or serious chronic illness including Crohn's disease, celiac disease, diverticulitis, chronic diarrhea, ulcerative colitis, gastritis
* History of cardiovascular disease including stroke, heart attack, or congestive heart failure
* Any history of arterial bypass or stent placement.
* History of emphysema or chronic obstructive pulmonary disease (COPD)
* Stage II hypertension (either systolic pressure \> 159 mm Hg or diastolic pressure 99 mm Hg)
* History of cancer during the previous 5 years
* Diabetes (type 1 or type 2) or use of drugs to lower blood sugar or increase insulin production or sensitivity
* Use of medications to lower cholesterol other than statins
* Use of medications to decrease fat or cholesterol absorption
* Unwillingness to refrain from taking dietary supplements (except calcium and vitamin D and vitamin B12), magnesium-containing drugs such as certain antacids, stool softeners and laxatives
* BMI \< 18.5 or \> 35
* Blood chemistry limits; any of the following at screening excludes participation:

* Fasting blood glucose ≥ 126 mg/dL
* LDL cholesterol ≥160 mg/dL
* Triglyceride ≥200 mg/dL
* High-sensitivity C-reactive protein (hsCRP) \> 10 mg/L
Minimum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hazelnut Marketing Board

UNKNOWN

Sponsor Role collaborator

Oregon State University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Maret Traber

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Maret G Traber, PhD

Role: PRINCIPAL_INVESTIGATOR

Oregon State University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Linus Pauling Science Center

Corvallis, Oregon, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Michels AJ, Leonard SW, Uesugi SL, Bobe G, Frei B, Traber MG. Daily Consumption of Oregon Hazelnuts Affects alpha-Tocopherol Status in Healthy Older Adults: A Pre-Post Intervention Study. J Nutr. 2018 Dec 1;148(12):1924-1930. doi: 10.1093/jn/nxy210.

Reference Type RESULT
PMID: 30517727 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

6988

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Soy and Isoflavones Effect on Bone
NCT00668447 COMPLETED PHASE4
Effect of Flax in Yogurt on Blood Cyanide Levels
NCT06491095 NOT_YET_RECRUITING NA
Flaxseed Mucilage and Satiety
NCT01238744 UNKNOWN NA
Fiber Tolerance Study
NCT06115057 COMPLETED EARLY_PHASE1